Actinium Pharmaceuticals, Inc. (Delaware)
Actinium Pharmaceuticals, Inc. (Delaware) financial statements
Actinium Pharmaceuticals, Inc. (Delaware)'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 90K | 10-K |
| Net income | −USD 33.89M | 10-K |
| Cash and equivalents | USD 48M | 10-Q |
| Total debt | USD 1.69M | EODHD |
Actinium Pharmaceuticals, Inc. (Delaware) financials on 6ix · Actinium Pharmaceuticals, Inc. (Delaware) on 6ix